Medical Properties Trust, Inc. (MPW) — Financial statements
Income statement, balance sheet, and cash flow for Medical Properties Trust, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 972↓2.4% | 996↑14.2% | 872↓43.5% | 1,543↓0.1% | 1,545 | |
| Cost of Revenue | 0.00↓100.0% | 27↓34.4% | 42↓9.0% | 46↑16.9% | 39 | |
| Gross Profit | 0.00↓100.0% | 968↑16.6% | 830↓44.5% | 1,497↓0.6% | 1,506 | |
| Operating Expenses | ||||||
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| General & Administrative Expenses | 130↓2.5% | 134↓8.1% | 146↓9.3% | 160↑10.2% | 146 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 130↓2.5% | 134↓8.1% | 146↓9.3% | 160↑10.2% | 146 | |
| Other Expenses | 842↑88.0% | 448↓25.8% | 603↑81.2% | 333↑3.7% | 321 | |
| Operating Expenses | 972↑67.2% | 581↓22.4% | 749↑51.8% | 493↑5.7% | 467 | |
| Total Costs & Expenses | 972↑59.7% | 609↓23.0% | 791↑46.6% | 539↑6.6% | 506 | |
| Operating Results | ||||||
| Operating Income | 0.00↓100.0% | 387↑375.9% | 81↓91.9% | 1,004↓3.4% | 1,039 | |
| Depreciation & Amortization | 265↓41.5% | 454↓26.4% | 616↑78.3% | 346↑3.5% | 334 | |
| EBITDA | 28↓96.7% | 841↑20.5% | 697↓48.3% | 1,349↓1.7% | 1,372 | |
| EBIT | -237↓161.3% | 387↑375.9% | 81↓91.9% | 1,004↓3.4% | 1,039 | |
| Interest & Other Income | ||||||
| Net Interest Income | 0.00↑100.0% | -422↓2.7% | -411↓11.5% | -368↑6.7% | -395 | |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 0.00↓100.0% | 422↑2.7% | 411↑11.5% | 368↓6.7% | 395 | |
| Non-Operating Income | 237 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Income / Expenses | 0.00↑100.0% | -2,751↓258.2% | -768↓1647.0% | -44↑85.7% | -308 | |
| Income Before Tax | -237↑90.0% | -2,364↓244.2% | -687↓171.6% | 960↑31.3% | 731 | |
| Income Tax Expense | -39↓187.6% | 44↑133.7% | -131↓333.8% | 56↓24.4% | 74 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -199↑91.7% | -2,408↓333.1% | -556↓161.5% | 904↑37.6% | 657 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -199↑91.8% | -2,410↓333.1% | -556↓161.7% | 903↑37.6% | 656 | |
| Bottom-Line Net Income | -199↑91.8% | -2,411↓332.0% | -558↓161.9% | 901↑37.8% | 654 | |
| EPS (Basic) | -0.33↑91.8% | -4.02↓332.3% | -0.93↓162.0% | 1.50↑35.1% | 1.11 | |
| EPS (Diluted) | -0.33↑91.8% | -4.02↓332.3% | -0.93↓162.0% | 1.50↑35.1% | 1.11 | |
| Weighted Average Shares | 601↑0.1% | 600↑0.3% | 599↓0.0% | 599↑1.7% | 589 | |
| Weighted Average Diluted Shares | 601↑0.1% | 600↑0.3% | 599↓0.1% | 599↑1.5% | 590 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.